Get a Second Opinion Emerges from Stealth with AI-Powered Medication Analysis Platform

What You Should Know:

–  Get a Second Opinion Inc. has officially emerged from stealth mode, unveiling its AI-powered platform designed to transform how patients understand and manage their medications.

– By analyzing a vast body of FDA data, clinical studies, and real-world outcomes, the company offers personalized insights that help patients make more informed decisions about prescription and over-the-counter (OTC) treatments.

Get a Second Opinion Launches AI-Driven Medication Analysis Platform to Empower Patients

The platform aims to close critical gaps in healthcare decision-making. According to the Mayo Clinic, nearly 70% of Americans take at least one prescription medication, and nearly half take two or more. Yet 76% of patients leave medical appointments confused, with 8 in 10 turning to online searches to clarify treatment options. Cost is another barrier: despite $30 billion in annual pharmaceutical marketing, almost one-third of Americans skip prescriptions due to affordability concerns.

Get a Second Opinion’s technology addresses these challenges through two key features:

·       The Discovery Tool analyzes a single medication or condition in the context of an individual’s health profile. It generates a report ranking potential options, supported by clinical data and cost comparisons—often surfacing more effective and affordable alternatives with fewer side effects.

·       The Planner reviews up to 10 medications across 10 conditions at once, identifying optimized treatment combinations while minimizing adverse interactions and redundant therapies.

According to CEO Joel Ferman, the platform empowers users to become “confident advocates” in their care by delivering insights in minutes that would traditionally take medical professionals weeks to compile.

Founded by two seasoned technology entrepreneurs with personal experience navigating the U.S. healthcare system, Get a Second Opinion was born out of frustration with opaque treatment plans and avoidable side effects. Their solution is built entirely in-house, with all data securely stored on domestic servers to ensure compliance and privacy.

By helping patients evaluate efficacy, safety, and affordability, Get a Second Opinion positions itself as a critical tool for improving health literacy and shared decision-making in an increasingly complex treatment landscape.